Evaluation of MK-870: a new potassium-sparing diuretic.
D000328:Adult; D000368:Aged; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004357:Drug Synergism; D004487:Edema / Q000188:drug therapy*; D004573:Electrolytes / Q000652:urine; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged
D004232:Diuretics; D004573:Electrolytes; D006852:Hydrochlorothiazide; D004976:Ethacrynic Acid